Bayview Acquisition Corp received notice that the Nasdaq board of directors declined to review a prior decision to delist the company's securities. Nasdaq will proceed with filing a Form 25-NSE to formally remove the company's units, ordinary shares, and rights from listing. The company is currently seeking to have its ordinary shares quoted on the OTC Pink Market.
Bayview Acquisition Corp deposited $50,000 into its trust account to extend the deadline for completing its initial business combination by one month. The extension moves the deadline from October 19, 2026, to November 19, 2026, and represents the fifth of six permitted monthly extensions.
Bayview Acquisition Corp received notice that the Nasdaq Listing and Hearing Review Council affirmed a prior decision to delist the company's securities. The delisting stems from the company's failure to complete its business combination with Oabay Inc. by the June 19, 2026 deadline. The company intends to transition the listing of its ordinary shares and rights to the OTC Pink Market.
Bayview Acquisition Corp deposited $50,000 into its trust account to extend the deadline for completing its initial business combination by one month. The extension moves the deadline from September 19, 2026, to October 19, 2026, and represents the fourth of six permitted monthly extensions.